{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T09:13:56Z","timestamp":1776417236736,"version":"3.51.2"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1007\/s12094-012-0807-1","type":"journal-article","created":{"date-parts":[[2012,5,7]],"date-time":"2012-05-07T00:14:46Z","timestamp":1336349686000},"page":"350-355","source":"Crossref","is-referenced-by-count":9,"title":["Episcleral brachytherapy for uveal melanoma: analysis of 136 cases"],"prefix":"10.1007","volume":"14","author":[{"given":"Ciro","family":"Garc\u00eda-\u00c1lvarez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Antonia","family":"Saornil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"L\u00f3pez-Lara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Almaraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Fe","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Frutos-Baraja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yerena","family":"Mui\u00f1os","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,5,8]]},"reference":[{"key":"807_CR1","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0161-6420(03)00078-2","volume":"110","author":"A. Singh","year":"2003","unstructured":"Singh A, Topham A (2003) Incidence of uveal melanoma in the United States: 1973\u20131997. Ophthalmology 110:956\u2013961","journal-title":"Ophthalmology"},{"key":"807_CR2","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archopht.119.7.969","volume":"119","author":"M. Diener-West","year":"2001","unstructured":"Diener-West M, Earle JD, Fine SL et al; Collaborative Ocular Melanoma Study Group (2001) The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18. Arch Ophthalmol 119:969\u2013982","journal-title":"Arch Ophthalmol"},{"key":"807_CR3","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s004170050279","volume":"237","author":"J.J. Augsburger","year":"1999","unstructured":"Augsburger JJ, Schneider S, Freyre J, Brady LW (1999) Survival following enucleation versus plaque radiotherapy in statistically matched subgroups of patients with choroidal melanomas: results in patients treated between 1980 and 1987. Graefes Arch Clin Exp Ophthalmol 237:558\u2013567","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"807_CR4","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1177\/107327480401100503","volume":"11","author":"J.B. Bell","year":"2004","unstructured":"Bell JB, Wilson MD (2004) Choroidal melanoma: natural history and management options. Cancer Control 11: 296\u2013303","journal-title":"Cancer Control"},{"key":"807_CR5","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0002-9394(98)00039-7","volume":"125","author":"COMS","year":"1998","unstructured":"COMS (1998) The Collaborative Ocular Melanoma Study (COMS) randomized trial of preenucleation radiation of large choroidal melanoma II: initial mortality findings. COMS Report No. 10. Am J Ophthalmol 125:779\u2013796","journal-title":"Am J Ophthalmol"},{"key":"807_CR6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0039-6257(97)00088-X","volume":"42","author":"P.T. Finger","year":"1997","unstructured":"Finger PT (1997) Radiation therapy for choroidal melanoma. Surv Ophthalmol 42:215\u2013232","journal-title":"Surv Ophthalmol"},{"key":"807_CR7","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0161-6420(99)90456-6","volume":"106","author":"M.W. Wilson","year":"1999","unstructured":"Wilson MW, Hungerford JL (1999) Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma. Ophthalmology 106:1579\u20131587","journal-title":"Ophthalmology"},{"key":"807_CR8","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0360-3016(03)00006-3","volume":"56","author":"S. Nag","year":"2003","unstructured":"Nag S, Quivey JM, Earle JD et al; American Brachytherapy Society (2003) The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas. Int J Radiat Oncol Biol Phys 56:544\u2013555","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"807_CR9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0039-6257(97)00088-X","volume":"42","author":"P.T. Finger","year":"1997","unstructured":"Finger PT (1997) Radiation therapy for choroidal melanoma. Surv Ophthalmol 42:215\u2013232. Review","journal-title":"Surv Ophthalmol"},{"key":"807_CR10","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1001\/archopht.1997.01100160565006","volume":"115","author":"M.A. Saornil","year":"1997","unstructured":"Saornil MA, Fisher MR, Campbell RJ et al (1997) Histopathologic study of eyes after iodine I 125 episcleral plaque irradiation for uveal melanoma. Arch Ophthalmol 115:1395\u20131400","journal-title":"Arch Ophthalmol"},{"key":"807_CR11","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1442-9071.2004.00917.x","volume":"32","author":"B. Damato","year":"2004","unstructured":"Damato B (2004) Developments in the management of uveal melanoma. Clin Experiment Ophthalmol 32:639\u2013647. Review","journal-title":"Clin Experiment Ophthalmol"},{"key":"807_CR12","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1177\/107327480401100504","volume":"11","author":"C.E. Margo","year":"2004","unstructured":"Margo CE (2004) The collaborative ocular melanoma study: an overview. Cancer Control 11:304\u2013309","journal-title":"Cancer Control"},{"key":"807_CR13","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1177\/107327480401100503","volume":"11","author":"D.J. Bell","year":"2004","unstructured":"Bell DJ, Wilson MW (2004) Choroidal melanoma: natural history and management options. Cancer Control 11:296\u2013303","journal-title":"Cancer Control"},{"key":"807_CR14","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0161-6420(98)99037-6","volume":"105","author":"J.J. Augsburger","year":"1998","unstructured":"Augsburger JJ, Correa ZM, Freire J, Brady LW (1998) Long-term survival in choroidal and ciliary body melanoma after enucleation versus plaque radiation therapy. Ophthalmology 105:1670\u20131678","journal-title":"Ophthalmology"},{"key":"807_CR15","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/archopht.118.9.1219","volume":"118","author":"C.L. Shields","year":"2000","unstructured":"Shields CL, Shields JA, Cater J et al (2000) Plaque radiotherapy for uveal melanoma: longterm visual outcome in 1106 consecutive patients. Arch Ophthalmol 118:1219\u20131228","journal-title":"Arch Ophthalmol"},{"key":"807_CR16","volume-title":"UICC: TNM classification of malignant tumours","author":"L.H. Sobin","year":"2002","unstructured":"Sobin LH, Wittekind Ch (2002) UICC: TNM classification of malignant tumours, 6th edn. Wiley, New York","edition":"6th edn."},{"key":"807_CR17","first-page":"29","volume":"77","author":"J.M. Caminal Mitjana","year":"2002","unstructured":"Caminal Mitjana JM, Quintana Casany M, Pera Fabregas J et al (2002) Results of Iodine-125 radiotherapy in the treatment of uveal melanoma. Arch Soc Esp Oftalmol 77:29\u201338","journal-title":"Arch Soc Esp Oftalmol"},{"key":"807_CR18","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0161-6420(02)01277-0","volume":"109","author":"COMS","year":"2002","unstructured":"COMS (2002) The Collaborative Ocular Melanoma Study (COMS) randomized trial of iodine 125 brachytherapy for choroidal melanoma IV: local treatment failure and enucleation in the first 5 years after brachytherapy. COMS Report No. 19. Ophthalmology 109:2197\u20132206","journal-title":"Ophthalmology"},{"key":"807_CR19","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/0360-3016(94)90314-X","volume":"30","author":"F. Valcarcel","year":"1994","unstructured":"Valcarcel F, Valverde S, Cardenes H et al (1994) Episcleral iridium-192 wire therapy for choroidal melanomas. Int J Radiat Oncol Biol Phys 30:1091\u20131097","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"807_CR20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ijrobp.2005.02.017","volume":"63","author":"B. Damato","year":"2005","unstructured":"Damato B, Patel I, Campbell IR et al (2005) Related articles, local tumor control after 106Ru brachytherapy of choroidal melanoma. Int J Radiat Oncol Biol Phys 63:385\u2013391","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"807_CR21","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.brachy.2009.03.189","volume":"8","author":"R. Correa","year":"2009","unstructured":"Correa R, Pera J, Gomez J et al (2009) 125 I plaque brachytherapy in the treatment of choroidal melanoma: a single institution experience in Spain. Brachytherapy 8:290\u2013296","journal-title":"Brachytherapy"},{"key":"807_CR22","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0161-6420(00)00526-1","volume":"108","author":"COMS","year":"2001","unstructured":"COMS (2001) The Collaborative Ocular Melanoma Study (COMS) randomized trial of iodine 125 brachytherapy for medium choroidal melanoma I: visual acuity after 3 years. COMS Report No. 16. Ophthalmology 108:348\u2013366","journal-title":"Ophthalmology"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-012-0807-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-012-0807-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-012-0807-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T09:14:25Z","timestamp":1561713265000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-012-0807-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["807"],"URL":"https:\/\/doi.org\/10.1007\/s12094-012-0807-1","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}